Due to the posting of clearly bashing news and a c
Post# of 72446
Posted On: 09/23/2015 11:35:31 AM
Due to the posting of clearly bashing news and a clear negative agenda... Here are the real filings of the company and not false shared information! If you are concerned feel free to look, my information doesn't lead you to links with pumper dumper sites and penny chasers, no fake companies filing fake information... GLTA
For links and clarity on all filings please go to Marketwired.com and search Cellceutix. You will find facts and real fillings!
Cellceutix Announces Brilacidin Data to Be Presented by ICPD at the Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC)
BEVERLY, MA --(Marketwired - September 16, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, is pleased to report that resul...
9/16/2015 7:40:09 AM
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Cellceutix Corporation
OKLAHOMA CITY, OK--(Marketwired - Sep 15, 2015) - On September 11, 2015, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Cellceutix Corporation ( OTC : CTIX ). The complaint alleges violations of federal s...
9/15/2015 11:38:18 AM
Cellceutix Announces Filing of Its Annual Report on Form 10-K
BEVERLY, MA --(Marketwired - September 14, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, has filed its A...
9/14/2015 9:00:00 AM
Cellceutix Plans for Phase 2 Clinical Trial in Ovarian Cancer
BEVERLY, MA --(Marketwired - September 08, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to a...
9/8/2015 7:00:00 AM
Cellceutix Requesting Meeting With FDA on Kevetrin for Pediatric Retinoblastoma
BEVERLY, MA --(Marketwired - August 24, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is requesting a me...
8/24/2015 7:00:00 AM
Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting Its Goals, Approaching End of Trial
BEVERLY, MA --(Marketwired - August 20, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, today discussed th...
8/20/2015 7:39:03 AM
Cellceutix' Kevetrin and Thymoma -- a Rare Cancer
BEVERLY, MA --(Marketwired - August 11, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to prov...
8/11/2015 8:30:24 AM
Cellceutix: Thank You
BEVERLY, MA --(Marketwired - August 10, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to than...
8/10/2015 8:31:43 AM
Cellceutix Provides Insights to Its Four Clinical Trials for the Treatment of ABSSSI (Completed Phase 2), Anti-Cancer (Phase 1), Psoriasis (Phase 2), and Oral Mucositis in Head and Neck Cancer Patients (Phase 2)
BEVERLY, MA --(Marketwired - August 07, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to addr...
8/7/2015 9:31:20 AM
Cellceutix Commences Phase 2 Trial of Prurisol as New Treatment for Psoriasis
BEVERLY, MA --(Marketwired - August 06, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company", a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to anno...
8/6/2015 8:30:00 AM
For links and clarity on all filings please go to Marketwired.com and search Cellceutix. You will find facts and real fillings!
Cellceutix Announces Brilacidin Data to Be Presented by ICPD at the Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC)
BEVERLY, MA --(Marketwired - September 16, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology and antimicrobial applications, is pleased to report that resul... 9/16/2015 7:40:09 AM
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Cellceutix Corporation
OKLAHOMA CITY, OK--(Marketwired - Sep 15, 2015) - On September 11, 2015, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Cellceutix Corporation ( OTC : CTIX ). The complaint alleges violations of federal s...
9/15/2015 11:38:18 AM
Cellceutix Announces Filing of Its Annual Report on Form 10-K
BEVERLY, MA --(Marketwired - September 14, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, has filed its A... 9/14/2015 9:00:00 AM
Cellceutix Plans for Phase 2 Clinical Trial in Ovarian Cancer
BEVERLY, MA --(Marketwired - September 08, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to a... 9/8/2015 7:00:00 AM
Cellceutix Requesting Meeting With FDA on Kevetrin for Pediatric Retinoblastoma
BEVERLY, MA --(Marketwired - August 24, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is requesting a me... 8/24/2015 7:00:00 AM
Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting Its Goals, Approaching End of Trial
BEVERLY, MA --(Marketwired - August 20, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, today discussed th... 8/20/2015 7:39:03 AM
Cellceutix' Kevetrin and Thymoma -- a Rare Cancer
BEVERLY, MA --(Marketwired - August 11, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to prov... 8/11/2015 8:30:24 AM
Cellceutix: Thank You
BEVERLY, MA --(Marketwired - August 10, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to than... 8/10/2015 8:31:43 AM
Cellceutix Provides Insights to Its Four Clinical Trials for the Treatment of ABSSSI (Completed Phase 2), Anti-Cancer (Phase 1), Psoriasis (Phase 2), and Oral Mucositis in Head and Neck Cancer Patients (Phase 2)
BEVERLY, MA --(Marketwired - August 07, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, would like to addr... 8/7/2015 9:31:20 AM
Cellceutix Commences Phase 2 Trial of Prurisol as New Treatment for Psoriasis
BEVERLY, MA --(Marketwired - August 06, 2015) - Cellceutix Corporation ( OTC : CTIX ) (the "Company"
, a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to anno... 8/6/2015 8:30:00 AM
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!